-
HLY78: Wnt/β-Catenin Pathway Modulator
2026-08-13
HLY78 provides a ligand-dependent way to amplify Wnt/β-catenin signaling through the Axin–LRP6 interface, supporting developmental, stem-cell, and mechanistic fibrosis assays. This guide translates that mechanism into cell and zebrafish workflows while showing how to distinguish pathway engagement from nonspecific toxicity or overinterpretation.
-
Notch Spatial Interactomes and Ataxin-2 Recycling
2026-08-13
Bian et al. mapped human NOTCH receptor interaction networks according to subcellular location using TurboID proximity labeling and affinity purification–mass spectrometry. The study identifies ER–Golgi intermediate compartment storage and ATXN2-dependent rapid recycling as mechanisms that help Notch receptors reach the plasma membrane, activate signaling, and contribute to leukemogenesis.
-
Social Memory Maintenance and NLG1 Proteolysis
2026-08-12
The reference study identifies secretase-generated Neuroligin 1 intracellular fragments as an active molecular link between social interaction and the maintenance of short-term social memory. Its perturbation and rescue experiments connect NLG1-CTD, PDZ-dependent signaling, cofilin regulation, and dendritic spine remodeling in the ventral hippocampus.
-
Norovirus Co-opts NINJ1 for Selective NS1 Secretion
2026-08-12
A 2025 Science Advances study shows that murine norovirus co-opts the host membrane-rupture factor NINJ1 to release the viral protein NS1 through a caspase-3–dependent unconventional pathway. The work links viral replication-site remodeling, selective cargo recognition, and in vivo infection, providing a mechanistic framework for studying regulated protein release during enteric virus infection.
-
ATS-9R for Targeted Adipose Gene Silencing
2026-08-11
ATS-9R enables non-viral nucleic acid delivery to mature adipocytes and adipose tissue macrophages, making it useful for obesity-associated inflammation research and metabolic disease models. This workflow-focused guide covers complex formation, tissue-selective assay design, quantitative validation, and troubleshooting for siRNA, shRNA, and sgRNA/Cas9 studies.
-
2X Taq PCR Master Mix for Translational Assays
2026-08-10
Streamline endpoint PCR for genotyping, construct verification, sequence preparation, and TA cloning with a ready-to-use mix that includes loading dye. This workflow translates findings from a neuroblastoma glycosylation study into practical DNA assay decisions while clearly separating screening PCR from quantitative and spatial technologies.
-
Degarelix Acetate: Rapid Androgen Deprivation
2026-08-09
Laurence Klotz’s 2009 review examines degarelix acetate as a third-generation GnRH receptor antagonist designed to achieve rapid medical castration without the testosterone flare associated with GnRH agonists. The paper’s clinical synthesis highlights faster testosterone and prostate-specific antigen responses, monthly administration, and a safety profile comparable to established androgen-deprivation approaches.
-
U0126-EtOH: Practical MEK1/2 Inhibition Guide
2026-08-08
U0126-EtOH is a selective MEK1/2 inhibitor for connecting ERK phosphorylation to functional outcomes in neuronal, inflammatory, and leukemia assays. This workflow-focused guide covers solvent handling, pathway controls, assay selection, and troubleshooting for more interpretable MAPK/ERK signaling experiments.
-
Concanamycin A for Reliable Cell Assays
2026-08-07
Learn how Concanamycin A (SKU A8633) can clarify viability, apoptosis, trafficking, and invasion experiments through selective V-ATPase inhibition. This scenario-based guide covers assay interpretation, solvent compatibility, protocol optimization, and practical product selection for cancer biology research.
-
Z-VAD-FMK: Precision Apoptosis Inhibition for Cancer Researc
2026-08-07
Z-VAD-FMK empowers researchers to dissect caspase-mediated apoptosis and pyroptosis with unparalleled specificity. Its robust inhibition profile and compatibility with diverse experimental models make it the gold standard for apoptosis pathway and immune modulation studies.
-
Tapuy Lees Reduce Amyloid-β Toxicity and Neuronal Loss in C.
2026-08-06
This study demonstrates that Tapuy lees, a by-product of traditional Filipino rice wine fermentation, more effectively attenuate amyloid-β toxicity and dopaminergic neurodegeneration in C. elegans models of Alzheimer’s and Parkinson’s disease than the wine itself. The findings highlight the neuroprotective and antioxidant potential of fermentation by-products for translational neurodegenerative research.
-
Bismuth Subsalicylate: Advanced Protocols in GI Disorder Res
2026-08-06
Bismuth Subsalicylate (1,3,2λ2-benzodioxabismin-4-one) from APExBIO is redefining experimental rigor in gastrointestinal disorder research. This guide delivers actionable workflows, troubleshooting strategies, and comparative insights for maximizing data integrity and reproducibility in inflammation pathway modulation and membrane biology assays.
-
Tamoxifen in Translational Research: Beyond Estrogen Modulat
2026-08-05
Explore tamoxifen as a selective estrogen receptor modulator in advanced research. This article offers new insights into its roles in metabolic bone disease modeling, kinase inhibition, and conditional genetics, highlighting unique assay design considerations.
-
ARL4C Regulates Synoviocyte Proliferation in Rheumatoid Arth
2026-08-05
This study reveals that ARL4C is a pivotal regulator of fibroblast-like synoviocyte (FLS) proliferation and macrophage polarization in rheumatoid arthritis (RA), as shown by integrated single-cell and bulk RNA sequencing. The findings underscore ARL4C’s mechanistic role in joint inflammation, offering new directions for targeted RA therapies and cell cycle S-phase detection strategies.
-
Thiazovivin: ROCK Inhibitor Guidance for Stem Cell Protocols
2026-08-04
Thiazovivin addresses two key challenges in stem cell research: low survival of human embryonic stem cells (hESCs) after dissociation and inefficient reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs). It is best employed in defined in vitro workflows, not for diagnostic or therapeutic use. Researchers should avoid long-term storage of solutions and ensure application is limited to research contexts requiring enhanced cell viability and reproducibility.